Laboratory criteria for early threatened miscarriage
https://doi.org/10.51523/2708-6011.2022-19-2-09
Abstract
Objective. To determine the role of placental growth factor, fibronectin, certain hemostatic parameters and glycodelin in the genesis of early miscarriage.
Materials and methods. Venous blood, inpatient medical records (form No.003/u-07), prenatal records (form No.113/u-07) of 94 pregnant women. The software package "Statistica" 10.0 and the programming language "R" version 4.1 were used for statistical analysis.
Results. Placental growth factor, fibronectin and glycodelin can be considered as laboratory markers of miscarriage during the first trimester of gestation.
Conclusion. The markers of early reproductive losses we have identified underlie the development of endothelial and hemostasiological disorders and morphofunctional inferiority of the endometrium.
About the Authors
L. V. Kastsova
Grodno State Medical University
Belarus
Belarus
Liubou V. Kastsova, postgraduate student at the Department of Obstetrics and Gynecology
Grodno
L. V. Gutikova
Grodno State Medical University
Belarus
Belarus
Ludmila V. Gutikova, DMedSc, Professor, Head of the Department of Obstetrics and Gynecology
Grodno
M. N. Kurbat
Grodno State Medical University
Belarus
Belarus
Mikhail N. Kurbat, PhD (Med), Associate Professor, Head of the Research Laboratory
Grodno
V. R. Shulika
Grodno State Medical University
Belarus
Belarus
Valentina R. Shulika, researcher at the Research Laboratoty
Grodno
A. Z. Kastsova
Grodno University Clinic
Belarus
Belarus
Ala Z. Kastsova, physician
Grodno
References
1. Dobrohotova JuJe, Gankovskaja LV, Bahareva IV, Svitich OA, Malushenko SV, Magomedova AM. The role of immune mechanisms in the pathogenesis of miscarriage. Obstetrics and Gynecology. 2016;(7):5-10. (in Russ.). DOI: https://dx.doi.org/10.18565/aig.2016.7.5-10
2. Podzolkova NM, Skvorcova MJu, Sheveljova TV. Miscarriage of pregnancy. Moscow: GEOTAR-Media; 2013. 136 р. (in Russ.).
3. Koga K, Mor G. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am. J. Reprod. Immunol. 2010;63(6):587-600. DOI: https://doi.org/10.1111/j.1600-0897.2010.00848.x
4. Kan NE, Baranov II, Dikke GB, Tjutjunnik VL. Medical termination of pregnancy in the period from 12 to 22 weeks: indications, methods and results. Obstetrics and Gynecology. 2016;(4):11-15. (in Russ.). DOI: https://dx.doi.org/10.18565/aig.2016.4.11-15
5. Selihova MS, Kuznecova OA, Vdovin SV, Dmitrienko GV. Developing pregnancy: how to avoid losses in the future? Doktor. Ru. 2012;75(7):20-25. (in Russ.).
6. The R Development Core Team. Version 2.6.2 (2008-02-08) R: A Language and Environment for Statistical Computing [Electronic resource]. [date of access 2022 February 2]. Avilable from: http://softlibre.unizar.es/manuales/aplicaciones/r/fullrefman.pdf
7. Botasheva TL, Linde VA, Ermolova NV, Hlopina AV, Sargsjan OD, Barinova VV. Angiogenic factors and cytokines in women with physiological and complicated pregnancy, depending on the sex of the fetus. Tavricheskij mediko-biologicheskij vestnik. 2016;19(2):22-27. (in Russ.).
8. Ajlamazjan JeK, Stepanova OI, Sel’kov SA, Sokolov DI. Maternal immune system cells and trophoblast cells: «constructive cooperation» to achieve a common goal. Vestnik Rossiĭskoĭ akademii meditsinskikh nauk/Rossiĭskaia akademiia meditsinskikh nauk. 2013;(11):12-21. (in Russ.). DOI: http://dx.doi.org/10.15690/vramn.v68i11.837
9. Momot AP. The problem of thrombophilia in clinical practice. Russian Journal of Pediatric Hematology and Oncology. 2015;(1):37-48. (in Russ.). DOI: https://doi.org/10.17650/2311-1267-2015-1-36-48
10. Putilova NV, Bashmakova NV. Modern principles of management of patients with thrombophilia from the standpoint of evidence-based medicine. Obstetrics and Gynecology. 2012;(6):15-20. (in Russ.).
11. Suhih GT, Vanko LV. Immune factors in the etiology and pathogenesis of pregnancy complications. Obstetrics and Gynecology. 2012;(1):128-136. (in Russ.).
12. Mishutina OL. Morphogenetic role of fibronectin in the structural foundations of homeostasis. Vestnik of the Smolensk state medical academy. 2005;(1):119-121. (in Russ.).
13. Tishhenko AN, Lazurenko VV, Jurkova OV. Features of the endometrial receptor apparatus in women with undeveloped pregnancy. ScienceRise. 2015;5/4(10):20-24. (in Russ.).
14. Balhanov JuS, Kulinich SI. The value of glycodelin for the prognosis of pregnancy. Sibirskij medicinskij zhurnal. 2008;(8):49-51. (in Russ.).
15. Sidorova IS, Sheshukova NA. Non-developing pregnancy. Gynecology. 2006;8(2):4-7. [date of access 2021 October 30]. Available from: https://gynecology.orscience.ru/2079-5831/article/view/27731 (in Russ.).
Review
For citations:
Kastsova L.V., Gutikova L.V., Kurbat M.N., Shulika V.R., Kastsova A.Z. Laboratory criteria for early threatened miscarriage. Health and Ecology Issues. 2022;19(2):76-81. (In Russ.) https://doi.org/10.51523/2708-6011.2022-19-2-09
Views: 399
Email this article 